Dermatology News
- EADV 2023 Novel Subcutaneous Biologics Show Promise in AD
- Meta-Analysis: Suicide Risk Not Increased With Isotretinoin
- Dietary Supplements May Play a Role in Managing Vitiligo
- Pilonidal Disease: Study Finds Laser Hair Removal Beneficial
- Tapinarof Effective for AD in Patients as Young as 2 years
- Nail Psoriasis in Black Patients Often Overlooked
- Alert FDA Warns of Potentially Lethal Reaction to Seizure Meds
- HS: Positive Results Reported With Anti-IL17A/F Therapies
- EADV 2023 At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib
- Methotrexate Carries Higher Risk for Older CKD Patients
- Parent Concerns a Factor When Treating Patients With AD
- Questionnaire Measures Patient Satisfaction With Acne Tx
- Risks Quantified in Medically Optimized Pregnancy With Lupus
- Choosing the Right Approach to Cancer and Menopause Symptoms
- Circadian Calorie-Burning Cycles Altered in Obesity
- ACR 2023 IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA
- Lebrikizumab Gets the Nod in the EU for Atopic Dermatitis
- Before Signing an Offer Letter: Read This
- New Consensus Guide on Rare Drug Hypersensitivity Reaction
- Amazon Says Unapproved Eye Drops Being Removed From Website
- FDA Warns Amazon Against Sale of Unapproved Eye Drops
- Should Physicians Go to Work When Sick?
- Neoadj T-VEC May Improve Survival in Resectable Melanoma